Docket

40252

Intervet Canada Corp., et al. v. Jessica Gagnon, et al.

(Quebec) (Civil) (By Leave)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings
Date Proceeding Filed By
(if applicable)
2023-03-10 Close file on Leave
2023-03-09 Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2023-03-09 Judgment on leave sent to the parties
2023-03-09 Judgment of the Court on the application for leave to appeal, The motions for leave to intervene filed by Innovative Medicines Canada and the Canadian Animal Health Institute are dismissed. The application for leave to appeal from the judgment of the Court of Appeal of Quebec (Montréal), Numbers 500-09-029268-208 and 500-09-029290-210, 2022 QCCA 553, dated April 25, 2022, is dismissed with costs.
Dismissed, with costs
2023-03-09 Decision on motion for leave to intervene, See decision on application
Dismissed
2023-01-30 All materials on application for leave submitted to the Judges, for consideration by the Court
2023-01-30 Submission of motion for leave to intervene, Ka Br Row
2022-09-08 Reply to the motion for leave to intervene., (Letter Form), Reply to Response to CAHI's motion for intervention, Completed on: 2022-09-12, (Printed version filed on 2022-09-08) Canadian Animal Health Institute
2022-09-06 Reply to the motion for leave to intervene., (Letter Form), Completed on: 2022-09-14, (Printed version filed on 2022-09-08) Innovative Medicines Canada
2022-09-02 Response to the motion for leave to intervene, (Letter Form), Response to the Motion for Intervention from Innovative Medicines Canada, Completed on: 2022-09-15, (Printed version due on 2022-09-12) Intervet Canada Corp.
2022-09-02 Response to the motion for leave to intervene, (Letter Form), Response to the Motion for Intervention from The Canadian Animal Health Institute, Completed on: 2022-09-15, (Printed version due on 2022-09-12) Intervet Canada Corp.
2022-08-31 Response to the motion for leave to intervene, (Letter Form), Response to motion for intervention filed by CAHI, Completed on: 2022-09-12, (Printed version filed on 2022-09-02) Jessica Gagnon
2022-08-31 Response to the motion for leave to intervene, (Letter Form), Response to motion for intervention filed by IMC, Completed on: 2022-09-12, (Printed version filed on 2022-09-02) Jessica Gagnon
2022-08-29 Applicant's reply to respondent's argument, (Book Form), Completed on: 2022-09-12, (Printed version filed on 2022-08-31) Intervet Canada Corp.
2022-08-29 Notice of name, (Letter Form), (Printed version due on 2022-09-06) Canadian Animal Health Institute
2022-08-29 Motion for leave to intervene, (Book Form), Completed on: 2022-09-12, (Printed version filed on 2022-08-29) Canadian Animal Health Institute
2022-08-26 Notice of name, (Letter Form), (Printed version due on 2022-09-02) Innovative Medicines Canada
2022-08-26 Motion for leave to intervene, (Book Form), Completed on: 2022-09-12, (Printed version filed on 2022-08-26) Innovative Medicines Canada
2022-08-18 Certificate (on limitations to public access), (Letter Form), (Printed version due on 2022-08-25) Jessica Gagnon
2022-08-18 Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2022-08-25, (Printed version filed on 2022-08-22) Jessica Gagnon
2022-06-29 Letter acknowledging receipt of a complete application for leave to appeal, FILE OPENED 2022-06-29
2022-06-22 Certificate (on limitations to public access), (Letter Form), (Printed version filed on 2022-06-23) Intervet Canada Corp.
2022-06-22 Notice of name, (Letter Form), (Printed version filed on 2022-06-23) Intervet Canada Corp.
2022-06-22 Application for leave to appeal, (Book Form), (2 volumes), Completed on: 2022-06-22, (Printed version filed on 2022-06-23) Intervet Canada Corp.
 

loading